Cord blood DNA marks linked to early-onset pediatric atopic dermatitis
Official title: The impact of the cord blood methylome on early-onset pediatric atopic dermatitis
Funded at Henry Ford Health + Michigan State University Health Sciences · NIH-11365750 · Data updated 2026-11-12
A study will look at cord blood DNA methylation to find early clues for kids who develop atopic dermatitis and related allergies.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project start | June 24, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $784,314 |
| NIH project number | 1U01AI182151-01A1 |
| Project ID | NIH-11365750 on NIH RePORTER |
Who could benefit from this research
✓Could help
Newborns and children up to 11 years old, with a focus on those at heightened risk for atopic dermatitis and allergies, and their families.
✕Less likely to help
Children without the identified epigenetic risk patterns may not receive a benefit from this specific biomarker approach.
What this research studies
This project follows newborns from diverse communities to see if DNA methylation patterns in cord blood predict early atopic dermatitis and later allergies. It will use genome-wide DNA methylation sequencing to identify signals and validate them across several birth cohorts. The goal is to connect epigenetic marks at birth with disease risk, alongside genetic and environmental factors, to enable earlier prevention strategies. The study builds on a previously developed cord blood methylation score that distinguished early-onset AD, aiming to confirm and extend these findings in newborns.
Why it matters
Potential benefit: If successful, the research could lead to early identification of children at higher risk for atopic dermatitis and related allergic diseases, enabling earlier prevention efforts and personalized care.
How similar studies have gone: Previous work showed a cord blood methylation signature that could differentiate early-onset AD with high accuracy.
Where this research is happening
-
Henry Ford Health + Michigan State University Health Sciences
East Lansing, United States Active
Researchers
- Principal investigator: Eapen, Amy — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Eapen, Amy
Related research
Other NIH-funded projects on the same topics.
-
Stopping Atopic Dermatitis and Allergy: Preventing Food Allergy by Protecting the Skin
A large study in infants at high risk for allergies tests whether using a skin barrier cream together with early, proactive skin care can prevent peanut allergy and other food allergies.
-
SEAL Study: Preventing peanut allergy by protecting baby skin
This trial tests whether using a skin-emollient and proactive skin steroids early in life can prevent peanut allergy in high-risk infants.
-
SEAL Study: Prevent allergy by protecting the baby’s skin
A very young group of high-risk babies will try a early skin-care plan to reduce eczema and prevent peanut allergy.
-
Understanding how skin fungi affect atopic dermatitis in adults
A study will look at how the skin's fungal community influences atopic dermatitis in adults and whether this understanding could lead to new treatments.
-
Preventing eczema-related allergies by strengthening infants' skin barrier
This project will see if using a trilipid skin cream plus proactive mild topical steroids in infants with early dry skin or eczema lowers their chances of developing food allergies.
-
Personalized predictions for how atopic dermatitis may progress in kids and teens
A patient-friendly plan to forecast how early-onset eczema might evolve in children and young people using simple health clues and data from diverse settings.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.